Related Articles
Anterior gradient 2 regulates cancer progression in <em>TP53</em>‑wild‑type esophageal squamous cell carcinoma
AGR2 is associated with gastric cancer progression and poor survival
AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation
Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness
Possibility of inducing tumor cell senescence during therapy (Review)